Adenosine-induced vasodilation: receptor characterization in pulmonary circulation

Area of Science:

• Pulmonary Circulation Physiology
• Receptor Pharmacology
• Vascular Smooth Muscle Biology

Background:

• Adenosine plays a crucial role in regulating vascular smooth muscle relaxation within the pulmonary circulation.
• The A2 receptor subtype has been hypothesized to mediate adenosine-induced vasodilation (AIV).

Purpose of the Study:

• To investigate the specific adenosine receptor subtypes involved in mediating adenosine-induced vasodilation (AIV) in the pulmonary circulation.
• To determine the mechanism of AIV, specifically its independence from nitric oxide (NO) pathways.

Main Methods:

• Utilized an isolated, blood-perfused rat lung model to assess the hypoxic pressor response (HPR).
• Administered selective adenosine agonists (NECA, CGS-21680C, CCPA) and antagonists (8-(p-sulfophenyl)theophylline, 8-cyclopentyl-1,3-dipropylxanthine) to evaluate their effects on HPR and vasodilation.
• Investigated the involvement of K+ channel blockers and NO synthase inhibitors.

Main Results:

• Adenosine dose-dependently attenuated the hypoxic pressor response (HPR).
• Nonselective adenosine agonists, particularly 5'-(N-ethylcarboxamido)adenosine (NECA), mimicked AIV.
• Adenosine- and NECA-induced vasodilation were significantly attenuated by the nonselective A2 antagonist 8-(p-sulfophenyl)theophylline, but not by the A1 antagonist.
• Selective A2a and A1 agonists showed minimal vasodilatory effects.
• NECA-induced vasodilation was not affected by K+ channel blockers or NO synthase inhibition.

Conclusions:

• Adenosine-induced vasodilation in the pulmonary circulation is primarily mediated by the A2b receptor subtype.
• The mechanism of AIV is independent of nitric oxide production.
• Findings elucidate the specific receptor and pathway involved in adenosine-mediated pulmonary vasodilation.